Judge Lays Out BPCIA 'Patent Dance' Rules
Biosimilar makers must satisfy each step of the Biologics Price Competition and Innovation Act's "patent dance" if they hope to reduce damages that innovator companies can seek for infringement, a Massachusetts...To view the full article, register now.
Already a subscriber? Click here to view full article